Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron Patch vs Oral Ondansetron in Gyn Cancers
NCT01536392Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2012
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Granisetron Hydrochloride Nasal Spray in chemotherapy-induced nausea and vomiting (CINV), sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2012; status: completed.
02
Drugs
Granisetron Hydrochloride Nasal Spray
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01536392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01536392.